FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164915896> ?p ?o ?g. }

• W3164915896 endingPage "116224" @default.
• W3164915896 startingPage "116224" @default.
• W3164915896 abstract "Cabazitaxel is one of the most recently FDA-approved taxane anticancer agent. In view of the advantages in preclinical and clinical data of cabazitaxel over former toxoids, the synthesis and biological evaluation of novel cabazitaxel analogues were conducted. First, a novel semi-synthesis of cabazitaxel was described. This strategy is concise and efficient, which needs five steps from the 10-deacetylbaccatin III (10-DAB) moiety and a commercially available C13 side chain precursor with a 32% overall yield. Besides, this strategy avoids using many hazardous reagents that involved in the previously reported processes. Then, a panel of cabazitaxel analogues were prepared basing on this strategy. The cytotoxicity evaluations showed that the majority of these cabazitaxel analogues are potent against both A549 and KB cells and their corresponding drug-resistant cell lines KB/VCR, and A549/T, respectively. Further in vivo antitumor efficacies assessment of 7,10-di-O-methylthiomethyl (MTM) modified cabazitaxel (compounds 16 and 19) on SCID mice A549 xenograft model showed they both had similar antitumor activity to the cabazitaxel. Since compound 19 was observed causing more body wight loss on the mice than 16, these preliminary studies suggest 16 might be a potent drug candidate for further preclinical evaluation." @default.
• W3164915896 created "2021-06-07" @default.
• W3164915896 creator A5019254820 @default.
• W3164915896 creator A5019766538 @default.
• W3164915896 creator A5033054716 @default.
• W3164915896 creator A5039609176 @default.
• W3164915896 creator A5044193888 @default.
• W3164915896 creator A5069915147 @default.
• W3164915896 creator A5082454092 @default.
• W3164915896 date "2021-07-01" @default.
• W3164915896 modified "2023-10-13" @default.
• W3164915896 title "Synthesis and biological evaluation of novel cabazitaxel analogues" @default.
• W3164915896 cites W1486406645 @default.
• W3164915896 cites W1966699106 @default.
• W3164915896 cites W1966781966 @default.
• W3164915896 cites W1971914635 @default.
• W3164915896 cites W1974495452 @default.
• W3164915896 cites W1999179108 @default.
• W3164915896 cites W2004565152 @default.
• W3164915896 cites W2029733434 @default.
• W3164915896 cites W2029983028 @default.
• W3164915896 cites W2041157986 @default.
• W3164915896 cites W2042339019 @default.
• W3164915896 cites W2047535318 @default.
• W3164915896 cites W2047677189 @default.
• W3164915896 cites W2047837456 @default.
• W3164915896 cites W2051905300 @default.
• W3164915896 cites W2061010495 @default.
• W3164915896 cites W2084622325 @default.
• W3164915896 cites W2091992383 @default.
• W3164915896 cites W2105588189 @default.
• W3164915896 cites W2108022707 @default.
• W3164915896 cites W2136311117 @default.
• W3164915896 cites W2144040368 @default.
• W3164915896 cites W2174776416 @default.
• W3164915896 cites W2189686546 @default.
• W3164915896 cites W2330181854 @default.
• W3164915896 cites W2883548109 @default.
• W3164915896 doi "https://doi.org/10.1016/j.bmc.2021.116224" @default.
• W3164915896 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34058663" @default.
• W3164915896 hasPublicationYear "2021" @default.
• W3164915896 type Work @default.
• W3164915896 sameAs 3164915896 @default.
• W3164915896 citedByCount "3" @default.
• W3164915896 countsByYear W31649158962022 @default.
• W3164915896 countsByYear W31649158962023 @default.
• W3164915896 crossrefType "journal-article" @default.
• W3164915896 hasAuthorship W3164915896A5019254820 @default.
• W3164915896 hasAuthorship W3164915896A5019766538 @default.
• W3164915896 hasAuthorship W3164915896A5033054716 @default.
• W3164915896 hasAuthorship W3164915896A5039609176 @default.
• W3164915896 hasAuthorship W3164915896A5044193888 @default.
• W3164915896 hasAuthorship W3164915896A5069915147 @default.
• W3164915896 hasAuthorship W3164915896A5082454092 @default.
• W3164915896 hasConcept C109316439 @default.
• W3164915896 hasConcept C121608353 @default.
• W3164915896 hasConcept C126322002 @default.
• W3164915896 hasConcept C150903083 @default.
• W3164915896 hasConcept C185592680 @default.
• W3164915896 hasConcept C202751555 @default.
• W3164915896 hasConcept C207001950 @default.
• W3164915896 hasConcept C2777511904 @default.
• W3164915896 hasConcept C2777899217 @default.
• W3164915896 hasConcept C2778971682 @default.
• W3164915896 hasConcept C2780035454 @default.
• W3164915896 hasConcept C2780192828 @default.
• W3164915896 hasConcept C530470458 @default.
• W3164915896 hasConcept C55493867 @default.
• W3164915896 hasConcept C71924100 @default.
• W3164915896 hasConcept C86803240 @default.
• W3164915896 hasConcept C98274493 @default.
• W3164915896 hasConceptScore W3164915896C109316439 @default.
• W3164915896 hasConceptScore W3164915896C121608353 @default.
• W3164915896 hasConceptScore W3164915896C126322002 @default.
• W3164915896 hasConceptScore W3164915896C150903083 @default.
• W3164915896 hasConceptScore W3164915896C185592680 @default.
• W3164915896 hasConceptScore W3164915896C202751555 @default.
• W3164915896 hasConceptScore W3164915896C207001950 @default.
• W3164915896 hasConceptScore W3164915896C2777511904 @default.
• W3164915896 hasConceptScore W3164915896C2777899217 @default.
• W3164915896 hasConceptScore W3164915896C2778971682 @default.
• W3164915896 hasConceptScore W3164915896C2780035454 @default.
• W3164915896 hasConceptScore W3164915896C2780192828 @default.
• W3164915896 hasConceptScore W3164915896C530470458 @default.
• W3164915896 hasConceptScore W3164915896C55493867 @default.
• W3164915896 hasConceptScore W3164915896C71924100 @default.
• W3164915896 hasConceptScore W3164915896C86803240 @default.
• W3164915896 hasConceptScore W3164915896C98274493 @default.
• W3164915896 hasFunder F4320335960 @default.
• W3164915896 hasFunder F4320335988 @default.
• W3164915896 hasLocation W31649158961 @default.
• W3164915896 hasOpenAccess W3164915896 @default.
• W3164915896 hasPrimaryLocation W31649158961 @default.
• W3164915896 hasRelatedWork W2144439788 @default.
• W3164915896 hasRelatedWork W2151241358 @default.
• W3164915896 hasRelatedWork W2509022872 @default.
• W3164915896 hasRelatedWork W3129056703 @default.
• W3164915896 hasRelatedWork W4361883032 @default.

• next